Company Filing History:
Years Active: 1998
Title: Innovative Contributions of Timothy Joseph Zamb in Immunogenic Peptide Research
Introduction
Timothy Joseph Zamb, an accomplished inventor based in Stony Brook, NY, has made significant contributions to the field of immunogenic peptide research. With a total of two patents to his name, Zamb's work focuses on developing innovative therapies that target hormone-related conditions and diseases.
Latest Patents
Zamb's latest patent, titled "Immunogenic LHRH Peptide Constructs," presents groundbreaking methods for using immunogenic luteinizing hormone-releasing hormone (LHRH) peptides. These peptides are designed to suppress LHRH activity in both males and females. They offer potential treatments for various conditions, including prostatic hyperplasia, androgen-dependent carcinoma, endometriosis, and estrogen-dependent breast cancer. The patented peptides contain a helper T cell epitope at the C terminus, which aids in stimulating the immune response against LHRH. Additionally, the invention includes synthetic peptides with an invasin domain and methods for using these peptides to treat diseases or provide protective immunity.
Career Highlights
Timothy Joseph Zamb currently works at United Biomedical, Inc., where he continues to advance the field of peptide-based therapies. His innovations have opened new avenues for addressing critical health issues. His work reflects a commitment to harnessing the power of immunotherapy to improve patient outcomes in complex hormonal disorders.
Collaborations
Throughout his career, Zamb has collaborated with skilled professionals, including Anna Efim Ladd and Chang Yi Wang. These partnerships have fostered a collaborative environment conducive to innovation and research excellence.
Conclusion
Timothy Joseph Zamb stands out as a prominent figure in the field of immunogenic peptide research. His patents illustrate a profound understanding of the immune response and its application in treating significant health challenges. With ongoing collaborations and research, Zamb is poised to make even greater contributions to medical science in the future.